Entity Details
| Primary name |
KCNK9_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q9NPC2 |
| EntryName | KCNK9_HUMAN |
| FullName | Potassium channel subfamily K member 9 |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 374 |
| SequenceStatus | complete |
| DateCreated | 2001-04-27 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cell membrane |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR003092 | Two pore domain potassium channel, TASK family | Family | Family |
| IPR003280 | Two pore domain potassium channel | Family | Family |
| IPR005407 | Potassium channel subfamily K member 9 | Family | Family |
| IPR013099 | Potassium channel domain | Domain | Domain |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 612292 | OMIM | Birk-Barel syndrome (BIBARS) | A syndrome characterized by mental retardation, hypotonia, hyperactivity, and facial dysmorphism. BIBARS transmission pattern is consistent with autosomal dominant inheritance with paternal imprinting. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
| Drug | Name | Source | Type |
| DB00561 | Doxapram | Drugbank | small molecule |
| DB01159 | Halothane | Drugbank | small molecule |
Interactions
2 interactions